Core Viewpoint - Spring Medical, a leading domestic orthopedic medical device manufacturer, focuses on the research, production, and sales of implantable orthopedic medical devices, including dental metal and invisible orthodontics, and is currently in the design inspection phase for a customized porous tantalum dental implant product [2][3] Company Overview - Spring Medical is located in Tongzhou District, Beijing, and was established on February 12, 1998, with its listing date on December 30, 2021. The company specializes in implantable orthopedic medical devices, with main products including joint prosthetics and spinal implants [7][8] - The company's product range includes joint prosthetics for hip, knee, shoulder, and elbow joints, as well as a full series of spinal internal fixation systems. Its products are exported to various regions including Asia, South America, Africa, Oceania, and Europe [8] Financial Performance - For the period from January to September 2025, Spring Medical achieved operating revenue of 756 million yuan, representing a year-on-year growth of 48.75%, and a net profit attributable to shareholders of 192 million yuan, with a year-on-year increase of 213.21% [8] - Since its A-share listing, the company has distributed a total of 359 million yuan in dividends, with 309 million yuan distributed over the past three years [8] Market Position and Recognition - Spring Medical has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which is the highest honor for small and medium-sized enterprises in China, indicating its strong innovation capability and high market share [3] - The company has obtained registration certificates for hip and knee surgical robots and medical image processing software, showcasing its investment in smart medical technology [2][3] Shareholder Information - As of September 30, 2025, the top ten circulating shareholders include Hong Kong Central Clearing Limited and Central European Economic Selection Mixed A, both of which are new shareholders [9]
春立医疗跌0.69%,成交额3070.31万元,后市是否有机会?